RECRUITINGOBSERVATIONAL
DANIsh VASculitis Database (DANIVAS)
Disease Stratification in GCA and PMR to Inform Management and Reduce Disease and Treatment-related Damage
About This Trial
The aim of this national pragmatic observational study is to investigate whether the use of new diagnostic imaging modalities facilitates disease stratification that can potentially predict treatment response, relapse risk and complications and hence guide management strategies to improve disease control and reduce disease and treatment related damage.
Who May Be Eligible (Plain English)
Who May Qualify:
- Are diagnosed with GCA or PMR within the last 5 years
- Diagnosis is established by or confirmed by a rheumatologist (clinical expert opinion)
- Speak and understand Danish
- Are able to give signed and dated willing to sign a consent form
Who Should NOT Join This Trial:
- Denies or are not able to give willing to sign a consent form
- Are diagnosed with other systemic autoimmune conditions (where your immune system attacks your own body)s that out-rules the diagnosis of GCA or PMR
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Are diagnosed with GCA or PMR within the last 5 years
* Diagnosis is established by or confirmed by a rheumatologist (clinical expert opinion)
* Speak and understand Danish
* Are able to give signed and dated informed consent
Exclusion Criteria:
* Denies or are not able to give informed consent
* Are diagnosed with other systemic autoimmune diseases that out-rules the diagnosis of GCA or PMR
Locations (2)
Led og Bindevævssygdomme, Aarhus University Hospital
Aarhus, Denmark
Medicinsk klinik 2, Regionshospitalet Horsens
Horsens, Denmark